Advertisement

Arsenal Medical spinout 480 Biomedical Inc. of Watertown said it has started the first human trial of a bioresorbable scaffold aimed at treating peripheral artery disease by restoring blood flow to the leg.

SOURCE

Advertisement
Advertisement